Results 41 to 50 of about 3,069 (139)

Effectiveness of the 2023 Autumn XBB.1.5 COVID‐19 Booster During Summer 2024 in the EU/EEA: A VEBIS Electronic Health Record Network Study

open access: yesInfluenza and Other Respiratory Viruses, Volume 19, Issue 12, December 2025.
ABSTRACT Background After a period of low SARS‐CoV‐2 activity, viral circulation increased in Europe from May 2024, driven by immune‐evasive KP sublineages of the JN.1 variant. We estimated vaccine effectiveness (VE) of the XBB.1.5 dose administered in autumn 2023 against COVID‐19‐related hospitalisations and deaths in individuals 65 years of age or ...
James Humphreys   +22 more
wiley   +1 more source

As metamorfoses da dimensão da relação estado / mercado: a ruptura da ofensiva neoliberal frente a crise do COVID-19 = The metamorphoses of the state / market relationship dimension: the rupture of the neoliberal offensive in the face of the Covid crisis 19

open access: yesTextos & Contextos (Porto Alegre), 2021
O desenvolvimento da sociedade contemporânea, a partir das especificidades de cada momento histórico, acaba por reformular as políticas econômicas e sociais, alterando a relação Estado/Mercado, de tal maneira que opresente artigo busca desenvolver ...
Reis, Carlos Nelson dos   +1 more
doaj  

Condições pós-COVID: um estudo nos cuidados de saúde primários Portugueses

open access: yesRevista Portuguesa de Medicina Geral e Familiar, 2023
O Centro para Controlo e Prevenção de Doenças propõe o termo COVID longo ou condições pós-COVID para sintomas desenvolvidos durante ou após a COVID-19 e que persistem pelo menos dois meses, não sendo explicados por outros diagnósticos.
Tiago Gomes de Oliveira   +7 more
doaj   +1 more source

Uncovering Hyperhomocysteinemia: Global Risk Patterns and Molecular Disruption in Brain and Vascular Health

open access: yesJournal of Neurochemistry, Volume 169, Issue 12, December 2025.
Elevated homocysteine results from genetic variants, impaired one‐carbon metabolism, nutritional deficiencies, and metabolic disorders. Hyperhomocysteinemia drives oxidative stress, inflammation, excitotoxicity, and epigenetic disruption, affecting multiple organs and systems.
Osmar Vieira Ramires Júnior   +5 more
wiley   +1 more source

HLA‐B Serine 116 Confers Protection Against Severe COVID‐19 in a Cohort From Rio de Janeiro, Brazil

open access: yesHLA, Volume 106, Issue 6, December 2025.
ABSTRACT COVID‐19 is a respiratory disease caused by SARS‐CoV‐2, in which severe outcomes are primarily driven by an exacerbated immune response. The HLA region has been extensively investigated in COVID‐19 due to its central role in the immune response, although genetic associations vary across populations.
Maria Aparecida da Silva Pereira   +15 more
wiley   +1 more source

PREVALÊNCIA E FATORES ASSOCIADOS À COVID-19 GRAVE EM ADULTOS HOSPITALIZADOS NO ESTADO DO PARANÁ

open access: yesArquivos de Ciências da Saúde da UNIPAR
O presente estudo buscou analisar a prevalência e os fatores associados à necessidade de cuidados intensivos por adultos hospitalizados, devido à Covid-19, no estado do Paraná.
Natan David Pereira   +7 more
doaj   +1 more source

The Global Impact of COVID‐19 Control Measures on People With Dementia Living at Home and Their Carers: A Systematic Review of Quantitative and Qualitative Research Across 27 Countries

open access: yesBrain and Behavior, Volume 15, Issue 11, November 2025.
This graphical abstract summarizes the main findings of our systematic review about the global impacts of COVID‐19 control measures on people with dementia living at home and their carers : they were broadly consistent across regions. Our evidence synthesis highlights the critical need for decision‐makers to account for the needs of PWD and their ...
Yaohua Chen   +12 more
wiley   +1 more source

Modernizing diagnosis of Alzheimer's disease: A review of global trends and Asia‐specific perspectives

open access: yesAlzheimer's &Dementia, Volume 21, Issue 8, August 2025.
Abstract The landscape of Alzheimer's disease (AD) and related dementias (ADRD) diagnosis is evolving rapidly, driven by advances in disease understanding, biomarker tools, and disease‐modifying therapies. Modern diagnostic approaches emphasize biological precision, early detection, and dynamic frameworks that adapt to treatment‐induced changes in ...
Takeshi Iwatsubo   +43 more
wiley   +1 more source

Immunosenescence Profile Is Associated With Increased Susceptibility to Severe COVID‐19

open access: yesAging Cell, Volume 24, Issue 7, July 2025.
(A) A previous immunosenescence profile in individuals infected with SARS‐CoV2 creates a permissive environment for progression to severe COVID‐19: higher inflammaging, accumulation of exhausted/senescent T cells, an oligoclonal B‐cell repertoire, and accelerated epigenetic age.
Lucas Haniel A. Ventura   +40 more
wiley   +1 more source

Highly Atypical 2025 Influenza A Season in Brazil

open access: yes
Influenza and Other Respiratory Viruses, Volume 20, Issue 4, April 2026.
Tatiana P. Portella   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy